Aurobindo Pharma Re-appoints Ernst & Young as Internal Auditor

Aurobindo Pharma Ltd has re-appointed M/s. Ernst & Young LLP as its Internal Auditors for the period from June 2026 to May 2027. The decision was made during the Board of Directors meeting held on May 21, 2026. The re-appointment is in compliance with Regulation 30 of the SEBI Listing Regulations. The board meeting commenced at 4:30 p.m. and concluded at 6:25 p.m.